Thursday, June 30, 2022
    HomeHealthApplause-worthy cancer data & the long wait for Novavax

    Applause-worthy cancer data & the long wait for Novavax


    When is knowledge “practice-changing”? What number of Covid-19 vaccines do we’d like? And what does it imply when the FDA asks for extra time?

    We cowl all that and extra this week on “The Readout LOUD,” STAT’s biotech podcast. With the world’s largest most cancers convention simply concluded, we clarify a very powerful knowledge offered on the assembly, together with a blockbuster scientific trial that guarantees to alter the remedy of superior breast most cancers. We additionally talk about an FDA controversy within the making, a pair of latest Covid-19 vaccines, and the irritating technique of discovering new remedies for despair.

    For extra on what we cowl, right here’s the news from the American Society of Clinical Oncology meeting; right here’s the latest from Novavax; right here’s more on Moderna’s new Covid-19 vaccine; right here’s the news on Praxis Precision Medicines’ depression treatment; right here’s where you can find episodes of Color Code; right here’s where you can subscribe to the First Opinion Podcast; and right here’s our complete coverage of the Covid-19 pandemic.


    Make sure to join on Apple Podcasts, Spotify, StitcherGoogle Play, or wherever you get your podcasts.

    And in case you have any suggestions for us — matters to cowl, visitors to ask, vocal tics to stop — you’ll be able to electronic mail [email protected].

    Source link

    Related articles

    Stay Connected


    Latest posts